Sunday, July 27, 2014 Last update: 9:03 PM
FreshNews.com - All Company Technology News Since 1996

Merz Aesthetics Announces That Radiesse® Has Received AMEC’S Best Filler Trophy

Companies mentioned in this article: Merz North America

GREENSBORO, N.C. -- (BUSINESS WIRE) -- Merz Aesthetics, a division of Merz North America (U.S. affiliate of the global Merz Pharma Group), announces that Radiesse® has been awarded the Anti-Aging and Beauty Trophy for Best Filler at the most recent Anti-Aging Medicine European Congress (AMEC).

The recipients of this year’s Anti-Aging and Beauty Trophies at the Anti-Aging Medicine European Congress 2013 (AMEC 2013) were selected by a jury of twenty-seven physicians from around the world specializing in aesthetic dermatology, plastic surgery and anti-aging medicine1. Entries were submitted for consideration by product manufacturers and included clinical data as well as detailed product descriptions.

“I believe that Radiesse® deserved to be named Best Filler by AMEC because it is a truly unique product in the dermal filler category,“ said Dr. Heidi A. Waldorf, one of the members of the AMEC 2013 Jury. “By using Radiesse®, I am able to provide my patients with immediately visible, long-lasting results. As a result, I have found Radiesse® to be a high-quality, high-value treatment option for my patients.“

In addition to her work with the Anti-Aging Medicine European Congress, Dr. Heidi A. Waldorf serves as Director of Laser and Cosmetic Dermatology at The Mount Sinai Medical Center in New York, NY and Associate Clinical Professor of Dermatology at The Mount Sinai School of Medicine.

Since its approval by the U.S. FDA in 2006, Radiesse® has provided a unique treatment option for moderate to severe facial wrinkles and folds such as nasolabial folds. Radiesse® has proven to be an ideal volumizer, as it possesses higher levels of viscosity and elasticity than leading dermal fillers. It is differentiated by an advanced calcium-based microsphere technology that immediately replenishes lost volume and stimulates the production of a patient’s own natural collagen for long-lasting results.

“Here at Merz Aesthetics, we are extremely pleased that Radiesse® was named Best Filler at AMEC 2013. We believe that Radiesse® delivers exceptional results, delivering natural, subtle aesthetic correction at an excellent value. Many physicians in North America are currently rediscovering Radiesse®,“ said Jim Hartman, Vice President and Head of US Aesthetics/OTC for Merz North America.

About Radiesse®

Radiesse® is a dermal filler that temporarily adds volume to help smooth moderate to severe facial wrinkles and folds, such as nasolabial folds (the creases that extend from the corner of your nose to the corner of your mouth). Radiesse® is composed of calcium hydroxylapatite (CaHA) microspheres suspended in a water-based gel carrier.

About Merz Aesthetics

Merz Aesthetics is a division of Merz North America, a specialty healthcare company that develops and commercializes treatment solutions in aesthetics, dermatology and neurosciences in the U.S. and Canada. Merz Aesthetics is committed to developing high-quality aesthetic products and to providing outstanding service to physicians in the fields of aesthetic dermatology and plastic surgery. As part of the Merz Pharma Group of companies, Merz Aesthetics operates subsidiaries in 16 countries, leveraging more than a century of Merz’s healthcare expertise to provide innovative medical approaches that have earned the trust of patients and physicians worldwide. Merz Aesthetics is an important contributor to the U.S. aesthetics space, offering a well-balanced product portfolio that includes the dermal fillers Radiesse® Volumizing Filler and Belotero Balance®. For information about Merz Aesthetics’ full product portfolio, please visit www.merzusa.com.

BELOTERO is a registered trademark and Merz Aesthetics is a registered trademark of Merz Pharma GmbH & Co. KGaA. RADIESSE is a registered trademark of Merz North America, Inc.

RADIESSE® IMPORTANT SAFETY INFORMATION

Indication: RADIESSE® injectable implant is FDA-approved for subdermal implantation for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds.

Contraindications: RADIESSE injectable implant is contraindicated for patients with known hypersensitivity to any of the components, severe allergies manifested by a history of anaphylaxis, or history or presence of multiple severe allergies; and patients with bleeding disorders.

Warnings: Use of RADIESSE in any person with active skin inflammation or infection in or near the treatment should be deferred until the inflammatory or infectious process is controlled. Do not overcorrect (overfill) a contour deficiency with RADIESSE because the depression should gradually improve within several weeks as the treatment effect of RADIESSE occurs. The safety and effectiveness for use in the lips has not been established.

Precautions: RADIESSE contains calcium hydroxylapatite, radiopaqueparticles, that are visible on CT Scans and may be visible in standard radiography. Patients using medications that can prolong bleeding, such as aspirin or warfarin, may experience increased bruising or bleeding at the injection site.

Patients should minimize exposure of the treated area to extensive sun or heat exposure for approximately 24 hours after treatment or until any initial swelling and redness has resolved. RADIESSE is for Single Patient Use Only. Do not use if needle is bent. Do not re-shield used needles. Discard needles and syringes as potential biohazards.

Safety of RADIESSE beyond 3 years; in the periorbital area; with concomitant dermal therapies or other drugs or implants; in patients with susceptibility to keloid formation and hypertrophic scarring; in pregnancy, in breastfeeding females or in patients under 18 years has not been established. As with all skin-injection procedures, there is a risk of infection with RADIESSE. Patients with a history of herpetic eruption may experience reactivation of herpes.

Adverse Events: The most common serious adverse events with RADIESSE include necrosis, allergic reaction, edema and infection. Common adverse events with RADIESSE are generally mild in nature and short in duration and include bruising, redness, swelling, pain, itching and other local side effects. To report a problem with RADIESSE, please call Customer Service at 1.866.862.1211.

For Instructions for Use Document and complete Safety Information please see representative or go to www.radiesse.com.

Caution: Rx only.

1 Source: EuroMediCom – AMEC 2013


Copyright © Business Wire 2014
Contact:

Merz North America
Mariana Smith, Corporate Communications
336-217-2636
mobile: 336-339-0172
msmith@merzusa.com